There is no single “best” medication for anxiety. The most effective choice depends on the type of anxiety you have, how severe it is, and how your body responds to treatment. That said, a large network meta-analysis of 100 clinical trials involving over 28,600 participants found that most anxiety medications outperform placebo, and several classes stand out for balancing effectiveness with tolerability. Here’s what works, how each option compares, and what to realistically expect.
SSRIs and SNRIs: The Standard Starting Point
For generalized anxiety, social anxiety, and panic disorder, doctors typically start with medications that adjust serotonin levels in the brain. These come in two closely related classes. SSRIs (like escitalopram, sertraline, and fluoxetine) target serotonin alone. SNRIs (like venlafaxine and duloxetine) target both serotonin and norepinephrine, a second chemical messenger involved in the stress response.
In head-to-head comparisons across clinical trials, escitalopram and venlafaxine consistently rank among the most effective options that people also tolerate well enough to keep taking. Both showed meaningful reductions in anxiety scores and had lower rates of people dropping out of treatment compared to placebo. Duloxetine performs similarly. These medications don’t work instantly. Most people notice improvement after four to six weeks at the right dose, and for some it takes nine to 12 weeks to feel the full benefit. That delay is one of the biggest frustrations with this class of medication, but it’s a normal part of how they work.
Common side effects include nausea, sleep changes, sexual dysfunction, and weight shifts. These often improve after the first few weeks, though sexual side effects can persist. Among all the treatments studied in the large meta-analysis, agomelatine was the only medication that actually produced fewer side effects than placebo, making it a notable alternative in countries where it’s available (it is not currently approved in the United States).
Buspirone: A Non-Sedating Alternative
Buspirone works differently from antidepressants. It acts on serotonin receptors in a more targeted way, dialing down the activity of certain anxiety-related brain circuits without the sedation or dependence risk that comes with many other options. It’s approved specifically for generalized anxiety disorder.
In a prospective study of patients with anxiety symptoms, standardized anxiety scores dropped significantly over 12 weeks of buspirone treatment, with about 39% of patients meeting the threshold for a meaningful response. The typical starting dose is 15 mg per day. Buspirone has a genuine advantage in that it doesn’t cause sedation, doesn’t impair memory, and carries no risk of physical dependence. The trade-off is that it’s generally less potent than SSRIs or SNRIs for moderate to severe anxiety, and like those medications, it requires several weeks of daily use before you feel the effects. It won’t help if you take it only when you feel anxious.
Benzodiazepines: Fast but Short-Term
Benzodiazepines are the medications most people picture when they think of anxiety relief. They work within minutes to hours by enhancing the brain’s main calming chemical, producing rapid sedation and muscle relaxation. In the meta-analysis, several benzodiazepines ranked highly for raw effectiveness at reducing anxiety scores.
The catch is serious: clinical guidelines across multiple countries consistently recommend against using benzodiazepines as a routine first-line treatment. When they are prescribed, the recommended duration is less than four weeks. The reason is dependence. Your brain adapts to benzodiazepines quickly, which means you need higher doses to get the same effect, and stopping them can cause rebound anxiety that’s worse than what you started with. They also impair memory, slow reaction time, and increase fall risk, particularly in older adults.
That said, benzodiazepines still have a role. They’re sometimes prescribed as a short bridge during the weeks it takes for an SSRI or SNRI to kick in, or for acute situations where anxiety is disabling. The key distinction is between using them as a temporary tool versus relying on them as ongoing treatment.
Pregabalin: Gaining Ground
Pregabalin works by reducing the release of excitatory brain chemicals involved in the stress response. It’s widely used for generalized anxiety in Europe and parts of Asia, though it’s primarily approved for nerve pain and seizures in the United States. A recent meta-analysis found that pregabalin showed superior efficacy and safety compared to SSRIs, SNRIs, and benzodiazepines for generalized anxiety. People taking pregabalin were less likely to discontinue treatment (a proxy for tolerability), with only 3.5% stopping due to lack of effectiveness compared to 5.7% in comparison groups.
Pregabalin does cause drowsiness, dizziness, and dry mouth, especially at doses above 300 mg. It also carries some risk of dependence, though less than benzodiazepines. Its main practical advantage is a faster onset than SSRIs, with some patients noticing effects within the first week. If you’ve tried standard options without success, pregabalin is worth discussing with your doctor.
Beta-Blockers for Performance Anxiety
If your anxiety is situational, like public speaking, presentations, or auditions, beta-blockers occupy a different category entirely. They don’t affect your brain’s anxiety circuits directly. Instead, they block the physical symptoms of adrenaline: racing heart, shaking hands, sweaty palms, trembling voice. A typical dose for acute situational anxiety is 40 mg of propranolol, taken about an hour before the event. Beta-blockers won’t help with the ongoing worry of generalized anxiety, but for predictable, performance-related situations, they can be remarkably effective with minimal side effects.
How Medications Compare Overall
The network meta-analysis that pooled data from 100 trials ranked treatments by both effectiveness and acceptability. Looking at both dimensions together reveals some useful patterns. The medications with the highest raw effectiveness scores, like clomipramine (an older tricyclic antidepressant), also had the highest dropout rates, meaning people couldn’t tolerate the side effects well enough to keep taking them. The medications people tolerated best, like buspirone and certain benzodiazepines, weren’t always the most powerful.
The sweet spot, where strong anxiety reduction meets reasonable tolerability, is occupied by escitalopram, venlafaxine, duloxetine, pregabalin, and sertraline. These are the medications that consistently show up in the “worth trying first” tier across clinical reviews. Among them, escitalopram is often the starting recommendation because of its relatively clean side effect profile and strong evidence base.
What to Expect When Starting Treatment
The first few weeks on an SSRI or SNRI can feel counterintuitive. Some people experience a temporary increase in anxiety or jitteriness before the medication starts helping. This is a known effect, not a sign that the medication is wrong for you. Starting at a low dose and increasing gradually helps minimize this.
Finding the right medication often involves trial and adjustment. If the first option doesn’t work after an adequate trial (at least six to eight weeks at a therapeutic dose), switching to a different medication in the same class or a different class is standard practice. About half of people respond well to their first medication, and the odds improve with each subsequent trial.
Stopping Anxiety Medication Safely
One thing many people don’t anticipate is that stopping antidepressants requires a gradual taper. Quitting abruptly can trigger discontinuation syndrome, which typically begins within two to four days and includes flu-like symptoms, nausea, dizziness, burning or shock-like sensations, and ironically, a surge of anxiety. These symptoms resolve quickly if you resume the medication, but the broader point is that going off antidepressants safely can be a slow process. Each medication tapers differently, and the timeline varies from weeks to months depending on how long you’ve been taking it and the dose.
This doesn’t mean you’re “addicted.” Discontinuation syndrome is a physiological adjustment, not a craving or compulsion. But it does mean you should plan any medication changes with your prescriber rather than stopping on your own.
A Note on Younger Patients
All antidepressants carry an FDA boxed warning about increased risk of suicidal thinking in children and adolescents. A combined analysis of placebo-controlled trials found a 4% rate of suicidal thoughts or behavior in young people on antidepressants, compared to 2% on placebo. This risk is highest in the first few months of treatment and around dose changes. It doesn’t mean antidepressants are unsafe for younger patients, but it does mean close monitoring during early treatment is essential, with particular attention to agitation, irritability, and unusual behavior changes.